1423 POSTER Polymorphism Analysis in the AVADO Randomised Phase III Trial of First-line Bevacizumab (BEV) Combined With Docetaxel in HER2-negative Metastatic Breast Cancer (mBC)
Miles, D.W, De Haas, S.L, Romieu, G, Chan, A, Dirix, L, Cortes, J, Delmar, P.R, Scherer, S.J
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article